You are here: Home > Institute of Excellence (CPD) > CPD Events > Artificial Intelligence: Reshaping AMD Management

Artificial Intelligence: Reshaping AMD Management

Provider: Mivision

Contact: Nikki Byrne, [E], [P] 02 8336 8616

Activity Outline

The integration of artificial intelligence (AI) into age-related macular degeneration management heralds a new era of personalised care and precision medicine. With its ability to predict disease progression, identify biomarkers, and assist in treatment decision-making, AI offers a powerful tool to enhance visual outcomes for AMD patients.

word count: 3,043

Learning Objectives

  • Understand the role artificial intelligence can play in detection and management of AMD
  • Be aware of the accuracy that can be achieved when using AI to screen for AMD
  • Realise the logistical and financial benefits of AI screening

Max CPD hours awarded: 1.5

Session Information

Artificial Intelligence: Reshaping AMD Management
Duration of CPD Session/Module
Duration of CPD Session/Module inclusive of Assessment Component

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.